English | Español

Abbvie
Jamie Barrand | Jan 13, 2016

FDA grants priority review to new leukemia therapy
Jamie Barrand | Jan 8, 2016

FDA grants priority review to therapy for HCV, cirrhosis

Jamie Barrand | Jan 6, 2016

Study of follicular lymphoma combination therapy shows promise
Jamie Barrand | Dec 29, 2015

AbbVie researchers publish results of Venetoclax study
Jamie Barrand | Dec 3, 2015

FDA approves new drug application for hepatitis C therapy
Jamie Barrand | Dec 1, 2015

AbbVie launches hyperthyroidism education program
Jamie Barrand | Nov 20, 2015

AbbVie's hepatitis C drug study sees positive results
Jamie Barrand | Oct 10, 2015

AbbVie to market hepatitis C drug Viekirax in Japan

Trending
+ Pharmaceuticals
Patient Daily | May 28, 2025

University of California medical researcher: ‘The 340B program is not associated with an improvement in mortality for low-income patients'
+ Pharmaceuticals
Patient Daily | May 29, 2025

Executive director of COA on 340B reform: ‘Start with PBMs then mega hospitals that pocket 340B discounts’
+ Pharmaceuticals
Patient Daily | May 27, 2025

New study shows effectiveness of recent RSV prevention strategies
+ Pharmaceuticals
Patient Daily | Jun 2, 2025

PathAI collaborates with Northwestern Medicine on digital pathology advancements